Grade 3 infusion-related reaction because of cetuximab administered with 5-fluorouracil and cisplatin chemotherapy for a recurrent and metastatic head and neck cancer patient who received chlorpheniramine 5 mg, dexamethasone 13.2 mg, and aprepitant 125 mg premedication-Reference-Cited by-同舟云学术

Grade 3 infusion-related reaction because of cetuximab administered with 5-fluorouracil and cisplatin chemotherapy for a recurrent and metastatic head and neck cancer patient who received chlorpheniramine 5 mg, dexamethasone 13.2 mg, and aprepitant 125 mg premedication

Published:2020-01 Issue:1 Volume:3 Page:e21
ISSN:2032-7072
Container-title:European Journal of Oncology Pharmacy
language:en
Short-container-title:

Author:

Horinouchi Ai,Suzuki Shinya,Enokida Tomohiro,Kamata Hayato,Kaneko Asumi,Matsuyama Chihiro,Fujisawa Takao,Ueda Yuri,Okano Susumu,Kawasaki Toshikatsu,Tahara Makoto

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology,Oncology

Reference21 articles.

1. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med,2006

2. Platinum-based chemotherapy plus cetuximab in head and neck cancer;Vermorken;N Engl J Med,2008

3. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy;Vermorken;J Clin Oncol,2007

4. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer;Cunningham;N Engl J Med,2004

5. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor;Saltz;J Clin Oncol,2004

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2023-03-11